AA
CTSO icon

Ancora Advisors’s Cytosorbents Corp CTSO Stock Holding History

Ancora Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-400
Closed -$3K – 1746
2020
Q4 		$3K Sell
400
-400
-50% -$3.35K ﹤0.01% 1334
2020
Q3 		$6K Hold
800
– – ﹤0.01% 1207
2020
Q2 		$8K Buy
+800
New +$7.35K ﹤0.01% 1139

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ancora Advisors's CTSO Position: Q1 2021 in Review

Ancora Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 400 shares — an estimated $3K sold.

Ancora Advisors first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

  • Ancora Advisors reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
  • Ancora Advisors sold 400 Cytosorbents Corp shares in Q1 2021, an estimated $3K.
  • Ancora Advisors first reported a position in Cytosorbents Corp in Q2 2020 and held it in 3 quarters.
  • Ancora Advisors's Cytosorbents Corp position peaked at $8K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Ancora Advisors's 13F filing for Q1 2021, filed 14 May 2021.